David E. Huizenga cofounded and currently manages Tao Life Sciences LLC, an early stage life sciences technology development and investment company. Mr. Huizenga has been on the founding team of numerous life science companies, including involvement in successful acquisitions and exits. Mr. Huizenga has served in a variety of corporate management roles including currently, in his role for Tao Life Sciences, as Interim Chief Executive Officer for two of its portfolio companies: Klaren Technologies Inc., a company with novel sterilization technology to fight heathcare acquired infections in developed and underdeveloped countries around the world, and Moterum LLC, a patient mobility and rehabilitation company whose founding product is aimed at retraining stroke patients to relearn how to walk normally. Previously, Mr. Huizenga has served as the Chief Technology Officer of Zirus, Inc. where he was engaged in management of the Zirus patent portfolio, licensing, and competitive intelligence. Mr. Huizenga was a leader in the translation of the company’s science strategy to its patent and business strategy.
Before joining the Zirus team, Mr. Huizenga was a partner and the founding member and head of the Patent Team at Arnall Golden Gregory, and prior to this he was a shareholder, and the Chief Financial Officer and Vice President of Venture Investment at Needle & Rosenberg, PC. Mr. Huizenga serves on numerous corporate and non-profit boards. Mr. Huizenga obtained his Ph.D. from Harvard, in the laboratory of Jack Szostak, Nobel Laureate in Medicine, and his Law Degree from Emory University Law School, where he was a Woodruff Fellow.